JP2017025071A5 - - Google Patents

Download PDF

Info

Publication number
JP2017025071A5
JP2017025071A5 JP2016159713A JP2016159713A JP2017025071A5 JP 2017025071 A5 JP2017025071 A5 JP 2017025071A5 JP 2016159713 A JP2016159713 A JP 2016159713A JP 2016159713 A JP2016159713 A JP 2016159713A JP 2017025071 A5 JP2017025071 A5 JP 2017025071A5
Authority
JP
Japan
Prior art keywords
anticancer agent
agent according
group
hydrogen
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016159713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017025071A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017025071A publication Critical patent/JP2017025071A/ja
Publication of JP2017025071A5 publication Critical patent/JP2017025071A5/ja
Pending legal-status Critical Current

Links

JP2016159713A 2004-09-07 2016-08-16 塞栓剤からの薬物送達 Pending JP2017025071A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04255411.3 2004-09-07
EP04255411 2004-09-07

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015080262A Division JP2015180625A (ja) 2004-09-07 2015-04-09 塞栓剤からの薬物送達

Publications (2)

Publication Number Publication Date
JP2017025071A JP2017025071A (ja) 2017-02-02
JP2017025071A5 true JP2017025071A5 (enExample) 2017-03-09

Family

ID=34930630

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007529390A Expired - Lifetime JP5221134B2 (ja) 2004-09-07 2005-09-06 塞栓剤からの薬物送達
JP2012167295A Expired - Lifetime JP5792691B2 (ja) 2004-09-07 2012-07-27 塞栓剤からの薬物送達
JP2015080262A Pending JP2015180625A (ja) 2004-09-07 2015-04-09 塞栓剤からの薬物送達
JP2016159713A Pending JP2017025071A (ja) 2004-09-07 2016-08-16 塞栓剤からの薬物送達

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2007529390A Expired - Lifetime JP5221134B2 (ja) 2004-09-07 2005-09-06 塞栓剤からの薬物送達
JP2012167295A Expired - Lifetime JP5792691B2 (ja) 2004-09-07 2012-07-27 塞栓剤からの薬物送達
JP2015080262A Pending JP2015180625A (ja) 2004-09-07 2015-04-09 塞栓剤からの薬物送達

Country Status (11)

Country Link
US (3) US20070275991A1 (enExample)
EP (3) EP2269580A3 (enExample)
JP (4) JP5221134B2 (enExample)
CN (2) CN101052378A (enExample)
AT (1) ATE505185T1 (enExample)
AU (1) AU2005281483B2 (enExample)
CA (1) CA2579533C (enExample)
DE (1) DE602005027477D1 (enExample)
ES (1) ES2361919T3 (enExample)
HK (1) HK1198691A1 (enExample)
WO (1) WO2006027567A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267839B1 (en) 2000-03-24 2007-10-03 Biosphere Medical, Inc. Microspheres for active embolization
US20070281028A1 (en) * 2004-08-04 2007-12-06 Biocompatibles Uk Limited Drug Delivery of a Cox Inhibitor from Embolic Agents
KR20140090270A (ko) 2005-05-09 2014-07-16 바이오스피어 메디칼 에스.에이. 마이크로스피어 및 비이온성 조영제를 사용하는 조성물 및 방법
PL2034951T3 (pl) * 2006-06-22 2013-06-28 Biocompatibles Uk Ltd Produkt farmaceutyczny ulegający rehydratacji
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
TR201820076T4 (tr) * 2007-08-16 2019-01-21 Biocompatibles Uk Ltd İlaç kombinasyonlarının salımı.
CN104382862A (zh) * 2008-12-02 2015-03-04 生物相容英国有限公司 胰腺肿瘤治疗
US9724421B2 (en) 2010-11-29 2017-08-08 Centre Hospitalier Universitaire Vaudois Chemoembolization composition comprising anti-angiogenic agents
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
CN102336904B (zh) * 2011-09-29 2013-03-27 成都一平医药科技发展有限公司 一种喜树碱及其衍生物的多价peg修饰物及其用途
CN102397593B (zh) * 2011-11-11 2013-12-18 北京大学 X线下可显影的栓塞微粒及其制备方法和应用
US20150352050A1 (en) * 2012-11-15 2015-12-10 Utah-Inha Dds & Advanced Therapeutics Research Center Biodegradable microbeads with improved anticancer drug adsorptivity, containing albumin and dextran sulfate, and preparation method therefor
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
WO2014084530A1 (ko) 2012-11-27 2014-06-05 재단법인 유타 인하 디디에스 및 신의료기술개발공동연구소 음이온성 고분자를 포함하는 항암제 흡착능력이 향상된 생분해성 마이크로 비드 및 이의 제조방법
CN105814120B (zh) 2013-09-19 2019-07-05 泰尔茂株式会社 聚合物颗粒
KR102340388B1 (ko) 2013-09-19 2021-12-17 마이크로벤션, 인코포레이티드 중합체 필름
EP3065719A4 (en) 2013-11-08 2017-08-09 Terumo Corporation Polymer particles
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
JP2016124818A (ja) * 2014-12-26 2016-07-11 日本化薬株式会社 転移性肝癌治療薬及び転移性肝癌の治療方法
WO2016154592A1 (en) 2015-03-26 2016-09-29 Microvention, Inc. Embiolic particles
WO2016203337A2 (en) * 2015-06-14 2016-12-22 Mohan M Alapati Compositions and methods for the treatment of cancer
WO2016203352A2 (en) * 2015-06-14 2016-12-22 Mohan M Alapati Compositions and methods for the treatment of cancer
GB201515602D0 (en) 2015-09-03 2015-10-21 Biocompatibles Uk Ltd Polymers and microspheres
AU2017336785B2 (en) 2016-09-28 2019-12-05 Terumo Corporation Polymer particles
EP3630078B1 (en) 2017-05-26 2024-09-11 Bruin Biosciences, Inc. Chemoembolization agents
CN107812232A (zh) * 2017-11-08 2018-03-20 华威(深圳)医疗器械有限责任公司 可显影羧基改性聚乙烯醇微球栓塞剂及其制备工艺
ES2969226T3 (es) * 2018-11-30 2024-05-17 Nextbiomedical Co Ltd Partículas de hidrogel para quimioembolización que comprenden un polímero biodegradable
GB201918300D0 (en) * 2019-12-12 2020-01-29 Extruded Pharmaceuticals Ltd Chemotherapeutic drug implant

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032561A (en) * 1975-05-27 1977-06-28 The Upjohn Company 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1.sub.α compounds
US4224427A (en) 1978-06-01 1980-09-23 Ciba-Geigy Corporation Process for preparing hydrogels as spherical beads of large size
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4978713A (en) 1987-12-16 1990-12-18 Ciba-Geigy Corporation Polyvinyl alcohol derivatives containing pendant vinylic monomer reaction product units bound through ether groups and hydrogel contact lenses made therefrom
GB9023498D0 (en) 1990-10-29 1990-12-12 Biocompatibles Ltd Soft contact lens material
US5559235A (en) * 1991-10-29 1996-09-24 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
GB9301701D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New zwitterionic materials
GB9301702D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New materials
TW272976B (enExample) 1993-08-06 1996-03-21 Ciba Geigy Ag
GB9415926D0 (en) 1994-08-04 1994-09-28 Biocompatibles Ltd New materials
CA2192725C (en) * 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
WO2000029481A1 (en) 1998-11-13 2000-05-25 Biocompatibles Limited Anionic-cationic polyion complexes comprising zwitterionic monomer component
US6958212B1 (en) * 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
DE19905639A1 (de) * 1999-02-11 2000-08-17 Clariant Gmbh Wasserlösliche oder wasserquellbare Polymerisate
FR2793684B1 (fr) 1999-05-17 2001-08-10 Ethypharm Lab Prod Ethiques Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US6191119B1 (en) * 1999-10-15 2001-02-20 Supergen, Inc. Combination therapy including 9-nitro-20(S)-camptothecin
JP2002154963A (ja) * 2000-11-14 2002-05-28 Yakult Honsha Co Ltd 徐放性抗腫瘍剤
US7838699B2 (en) * 2002-05-08 2010-11-23 Biosphere Medical Embolization using degradable crosslinked hydrogels
DE10230991A1 (de) 2002-07-10 2004-02-12 Robert Bosch Gmbh Werkzeugaufnahme für eine Werkzeugmaschine
US20040076582A1 (en) * 2002-08-30 2004-04-22 Dimatteo Kristian Agent delivery particle
ES2308149T3 (es) * 2003-02-12 2008-12-01 Biocompatibles Uk Limited Composicion para la quimioemboloterapia de tumores solidos.
US20040161466A1 (en) * 2003-02-14 2004-08-19 Biocompatibles Uk Limited Chemoembolisation

Similar Documents

Publication Publication Date Title
CN102985452B (zh) 包含丙烯酸的碱溶胀性丙烯酸乳液、其在水性制剂中的用途以及含有所述乳液的制剂
CA2543553A1 (en) Nanoparticulate active substance formulations
JP2005515278A5 (enExample)
RU2016116942A (ru) Порошкообразный материал для формирования трехмерного изделия, жидкий отвердитель и набор для формирования трехмерного изделия, и способ формирования и устройство для формирования трехмерного изделия
JP2018156109A (ja) リソグラフィーによって生成された形体
JP2014087796A5 (enExample)
JP2007523235A5 (enExample)
JP2013214058A5 (enExample)
JP6262873B2 (ja) 歯科用グラスアイオノマーセメント組成物及びその製造方法
JP2016104119A5 (enExample)
BR112017022642B1 (pt) Composição, e, método
WO2016076116A1 (ja) 水系樹脂分散体および塗料
WO2012142126A3 (en) Method of making radiation-sensitive sol-gel materials
JP2011136977A5 (enExample)
CN104387519A (zh) 一种纳米阳离子氟碳聚合物乳液及其制备方法
JPWO2016104261A1 (ja) 結合剤および水溶液
JP2016020461A5 (enExample)
CN105153357B (zh) 一种氟封端的环氧聚合物和制备方法及其在制备疏水表面的应用
ES2592913T3 (es) Partículas nanocompuestas eléctricamente conductoras que poseen un núcleo de poliacrilato de alquilo y un recubrimiento de polianilina
JP2013540204A5 (enExample)
ES2833953T3 (es) Látex de polímero híbrido orgánico-inorgánico para pintura para señalización de tráfico de alta duración
EP3179310A3 (en) Intermediate transfer member and image forming apparatus
KR940005719A (ko) 수지입자, 그 제조방법 및 용도
WO2018181736A1 (ja) 水性分散液および水性分散液の製造方法
TW201925243A (zh) 聚合物粒子及其製造方法、以及含有該聚合物粒子之塗料液組成物、薄片、樹脂成形體、纖維及黏度調整劑